Kenji Onda

1.6k total citations
65 papers, 1.3k citations indexed

About

Kenji Onda is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kenji Onda has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Immunology. Recurrent topics in Kenji Onda's work include Retinoids in leukemia and cellular processes (14 papers), Pregnancy and preeclampsia studies (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Kenji Onda is often cited by papers focused on Retinoids in leukemia and cellular processes (14 papers), Pregnancy and preeclampsia studies (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Kenji Onda collaborates with scholars based in Japan, China and Australia. Kenji Onda's co-authors include Toshihiko Hirano, Sachiko Tanaka, Natalie J. Hannan, Tu’uhevaha J. Kaitu’u‐Lino, Stephen Tong, Fiona Brownfoot, Kentaro Sugiyama, Kitaro Oka, Natalie Binder and Roxanne Hastie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Kenji Onda

63 papers receiving 1.3k citations

Peers

Kenji Onda
Nina Grosser Germany
C.J. Packard United Kingdom
Leslie J. Dickmann United States
Kenji Onda
Citations per year, relative to Kenji Onda Kenji Onda (= 1×) peers Kamil Biringer

Countries citing papers authored by Kenji Onda

Since Specialization
Citations

This map shows the geographic impact of Kenji Onda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Onda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Onda more than expected).

Fields of papers citing papers by Kenji Onda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Onda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Onda. The network helps show where Kenji Onda may publish in the future.

Co-authorship network of co-authors of Kenji Onda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Onda. A scholar is included among the top collaborators of Kenji Onda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Onda. Kenji Onda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wencheng, Xiaoqin Wang, Sachiko Tanaka, et al.. (2024). Cepharanthine synergistically promotes methylprednisolone pharmacodynamics against human peripheral blood mononuclear cells possibly via regulation of P-glycoprotein/glucocorticoid receptor translocation. BMC Complementary Medicine and Therapies. 24(1). 186–186. 2 indexed citations
3.
Beard, Sally, et al.. (2022). Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease. International Journal of Molecular Sciences. 23(17). 9533–9533. 5 indexed citations
4.
Azuma, Kanako, Takashi Kawaguchi, Takuhiro Yamaguchi, et al.. (2021). Development of Japanese Versions of the Control Preferences Scale and Information Needs Questionnaire: Role of Decision-Making and Information Needs for Japanese Breast Cancer Patients. Patient Preference and Adherence. Volume 15. 1017–1026. 6 indexed citations
5.
Xu, Wencheng, Xiaoqin Wang, Sachiko Tanaka, et al.. (2020). Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases. Pharmacology & Therapeutics. 217. 107659–107659. 36 indexed citations
6.
Onda, Kenji, et al.. (2019). Bevacizumab Versus Anti-preeclamptic Drugs: Evaluation With Three-dimensionally Co-cultured Human Mini Tumors. Anticancer Research. 39(7). 3543–3551. 3 indexed citations
7.
Hannan, Natalie J., Sally Beard, Natalie Binder, et al.. (2017). Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction. Placenta. 51. 1–9. 31 indexed citations
8.
Sugiyama, Kentaro, et al.. (2016). Effects of insulin on pharmacodynamics of immunosuppressive drugs against mitogen-activated human peripheral blood mononuclear cells. Immunopharmacology and Immunotoxicology. 38(5). 372–378. 4 indexed citations
9.
Nakamura, Y., Akemi Hayakawa, Yuzuru Kamei, et al.. (2015). Immunomodulatory effects of the pentapeptide YGSRS on human peripheral-blood mononuclear cells. Immunopharmacology and Immunotoxicology. 37(3). 318–323. 2 indexed citations
10.
Makita, Masujiro, Takuji Iwase, Sachiko Tanaka, et al.. (2015). Clinical Significance of Female-hormones and Cytokines in Breast Cancer Patients Complicated with Aromatase Inhibitor-related Osteoarthropathy - Efficacy of Vitamin E. Journal of Cancer. 6(4). 367–376. 3 indexed citations
11.
Makita, Masujiro, Na Li, Sachiko Tanaka, et al.. (2015). Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients. Translational Oncology. 8(4). 318–326. 12 indexed citations
12.
Nakamura, Y., Hiroko Tadokoro, Sachiko Tanaka, et al.. (2014). Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sciences. 99(1-2). 61–68. 24 indexed citations
13.
Brownfoot, Fiona, Natalie J. Hannan, Kenji Onda, Stephen Tong, & Tu’uhevaha J. Kaitu’u‐Lino. (2014). Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Placenta. 35(9). 724–731. 36 indexed citations
14.
Hu, Xiaomei, Kenji Onda, Sachiko Tanaka, et al.. (2013). Dose-dependent biphasic effects of arsenic disulfide on differentiation and apoptosis of HL-60 cells. 17(2). 13–25. 2 indexed citations
17.
Shibuya, Akiko, Kenji Onda, Yuka Uchiyama, et al.. (2010). Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase-1 dependent pathway in gastric epithelial cells. Biochemical and Biophysical Research Communications. 398(3). 581–584. 36 indexed citations
18.
Onda, Kenji, Masahiro Nagashima, Yo Kawakubo, et al.. (2006). Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFα in human epidermal keratinocytes (HaCaT). Biochemical and Biophysical Research Communications. 351(1). 266–272. 26 indexed citations
19.
Hirano, Toshihiko, et al.. (2004). MDR1 mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Ulcerative Colitis in Relation to Glucocorticoid Administration. The Journal of Clinical Pharmacology. 44(5). 481–486. 24 indexed citations
20.
Takahashi, Eriko, Kenji Onda, Toshihiko Hirano, et al.. (2002). Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma. International Immunopharmacology. 2(10). 1419–1427. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026